Home/Filings/4/0001638599-17-000230
4//SEC Filing

AYTU BIOSCIENCE, INC 4

Accession 0001638599-17-000230

$AYTUCIK 0001385818operating

Filed

Feb 28, 7:00 PM ET

Accepted

Mar 1, 6:43 PM ET

Size

12.0 KB

Accession

0001638599-17-000230

Insider Transaction Report

Form 4
Period: 2017-02-27
Disbrow Jarrett
Chief Business Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2017-02-27$0.75/sh+187,500$140,625601,004 total
  • Exercise/Conversion

    Warrant to Purchase Common Stock

    2017-02-2720,8340 total
    Exercise: $6.00From: 2016-05-06Exp: 2021-05-06Common Stock (20,834 underlying)
  • Exercise/Conversion

    Warrant to Purchase Common Stock

    2017-02-27166,6660 total
    Exercise: $1.86From: 2017-11-02Exp: 2021-11-02Common Stock (166,666 underlying)
Holdings
  • Employee Stock Option Grant

    Exercise: $3.23Exp: 2025-11-11Common Stock (50,000 underlying)
    50,000
  • Employee Stock Option Grant

    Exercise: $3.23Exp: 2026-07-07Common Stock (60,000 underlying)
    60,000
Footnotes (3)
  • [F1]Of these shares, 165,000 are restricted shares that vest on July 7, 2026, subject to earlier vesting in certain situations.
  • [F2]33.3% vest on November 11, 2016, 33.3% vest on November 11, 2017 and 33.3% vest on November 11, 2018, subject to the Grantee's continued service as an employee on such dates.
  • [F3]33.3% vests on the one year, two year and three year anniversary of the date of grant, subject to the Grantee's continued service as an employee on such dates.

Issuer

AYTU BIOSCIENCE, INC

CIK 0001385818

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001385818

Filing Metadata

Form type
4
Filed
Feb 28, 7:00 PM ET
Accepted
Mar 1, 6:43 PM ET
Size
12.0 KB